At a time when the world is plagued by the COVID-19 crisis and when there is no approved medicine/ vaccine for managing it, Pharmacovigilance professionals are busy, remotely processing and reporting adverse event reports. In such a situation, it is quite reasonable that one may come across any of the following eleven scenarios: 1. COVID-19 […]